Ignite Creation Date:
2024-05-06 @ 7:31 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06048094
Status:
RECRUITING
Last Update Posted:
2024-04-18
First Post:
2023-09-15
Brief Title:
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
Sponsor:
Baptist Health South Florida
Organization:
Baptist Health South Florida
Study Overview
Official Title:
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery FACILITATE
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FACILITATE
Brief Summary:
This is a pilot imaging study in participants treated with stereotactic radiosurgery SRS to treat brain metastasis The purpose of this study is to see whether 18F-Fluciclovine positron emission tomography PET can be used as a biomarker to measure response or progression of brain metastasis after SRS
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None